Philadelphia
Novartis is partnering with the University of Pennsylvania to create the Center for Advanced Cellular Therapeutics. Located on the Penn Medicine Campus in Philadelphia, the 30,000-sf facility will accommodate research on personalized cellular cancer therapies using chimeric antigen receptor technology (CAR). Supported by $20 million in funding from Novartis, the project will be built on top of the Jordan Medical Education Center and South Pavilion Extension, which is currently under construction. Completion is expected in 2016.
Source
